Live Breaking News & Updates on ஒழுங்குமுறை சிகிச்சை
Stay updated with breaking news from ஒழுங்குமுறை சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulus Therapeutics Announces Completion of Dosing in the First Cohort of Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) News provided by Share this article LA JOLLA, Calif., April 15, 2021 /PRNewswire/ Regulus Therapeutics Inc . (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the Company or Regulus ), today announced that it completed dosing in the first cohort of nine patients with ADPKD in its Phase 1b clinical trial of RGLS4326. The study is evaluating the safety, pharmacokinetics, and biomarkers (polycystin 1 (PC1) and polycystin 2 (PC2)) of multiple doses of RGLS4326 in patients with ADPKD. ....
Global Oligonucleotide Therapeutics Market SWOT Analysis,Key Indicators,Forecast 2027 : PCI Biotech, SomaGenics, ContraVir, Alnylam – KSU ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
3 Penny Stocks to Buy for Under $2 But Are They Worth It? dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.
Regulus Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference News provided by Share this article LA JOLLA, Calif., April 7, 2021 /PRNewswire/ Regulus Therapeutics Inc . (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs ( Regulus ), today announced that Jay Hagan, President and Chief Executive Officer of Regulus, will present at the 20 th Annual Needham Healtchare Conference on Thursday, April 15 th at 1:30 P.M. ET. A live webcast of the presentation will be available on the investor relations section of the Company s website at www.regulusrx.com. A replay of the webcast will be archived for 30 days following the presentation date. ....
Form 6-K Fresenius Medical Care For: Apr 07 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.